世界の抗ウイルス薬市場2020-2027:種類別(ブランド、ジェネリック)、用途別、薬剤クラス別、地域別

◆英語タイトル:Global Antiviral Drugs Market Size study, by Type (Branded, Generics), by Application (HIV, Hepatitis, Herpes, Influenza, Others), by Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Others) and Regional Forecasts 2020-2027
◆商品コード:BZW21AP012
◆発行会社(リサーチ会社):Bizwit Research&Consulting
◆発行日:2021年2月16日
◆ページ数:約200
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:アメリカ、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、GCC諸国
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥544,500見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥687,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はBizwit Research&Consulting社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Bizwit Research&Consulting社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本書では、世界の抗ウイルス薬市場を調査対象とし、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、種類別(ブランド、ジェネリック)分析、用途別(HIV、肝炎、ヘルペス、インフルエンザ、その他)分析、薬剤クラス別(DNAポリメラーゼ阻害剤、逆転写酵素阻害剤、プロテアーゼ阻害剤、ノイラミニダーゼ阻害剤、その他)分析、地域別分析、競争状況、調査プロセスなどを整理しました。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・世界の抗ウイルス薬市場規模:種類別(ブランド、ジェネリック)
・世界の抗ウイルス薬市場規模:用途別(HIV、肝炎、ヘルペス、インフルエンザ、その他)
・世界の抗ウイルス薬市場規模:薬剤クラス別(DNAポリメラーゼ阻害剤、逆転写酵素阻害剤、プロテアーゼ阻害剤、ノイラミニダーゼ阻害剤、その他)
・世界の抗ウイルス薬市場規模:地域別
・競争状況
・調査プロセス
【レポートの概要】

Global Antiviral Drugs Market is valued at approximately USD 37.26 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 3.2% over the forecast period 2020-2027. Antiviral drugs belong to the class of medication, which used for curing viral infections, such as HIV, hepatitis, influenza, and herpes. Usually, these drugs are overseen in the form of vaccines. In addition, most of these drugs are utilized for viral infections, even though a few broad-spectrum antiviral drugs are efficient alongside a comprehensive range of viruses. These drugs can reduce the ability of flu viruses to produce. When used as directed, antiviral drugs may often help to lessen the duration of flu symptoms in else healthy children and adults and may lower the severity of frequent flu symptoms. Therefore, these factors may promote the adoption of antiviral drugs for the treatment of viral infections all over the world. Therefore, the rise in prevalence of viral infections, such as HIV and influenza, along with the rise in R&D activities and development of advanced and newer formulations are the few factors responsible for the high CAGR of the market during the forecast period.

As per the Avert organization, around 37.9 million people were affected by HIV (including 1.7 million children) in 2018, with a global prevalence of HIV of about 0.8% in the adult population. Similarly, according to the U.S. Department of Health & Human Services, in 2017, roughly 21.7 million individuals living with HIV, representing a surge of 8 million since 2010. Thus, the rise in prevalence of HIV diseases throughout the world will foster the demand for antiviral drugs in the forthcoming period. However, the high cost of drug development, coupled with availability of alternative treatment options, such as homeopathy and naturopathy, are the few major factors inhibiting the market growth over the forecast period of 2020-2027.

The regional analysis of the global Antiviral Drugs market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the rise in availability of sophisticated healthcare infrastructure, and the presence of a significant number of market vendors in the region. Whereas Asia-Pacific is anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as the rise in prevalence of infectious diseases, along with the improving healthcare infrastructure in developing countries, such as China and India, would create lucrative growth prospects for the Antiviral Drugs market across the Asia-Pacific region.

Major market player included in this report are:
Gilead Sciences
F. Hoffmann-La Roche AG
GlaxoSmithKline plc.
AbbVie
Merck & Co., Inc.
Johnson & Johnson Services, Inc.
Bristol-Myers Squibb Company
Cipla Inc.
Aurobindo Pharma
Dr. Reddy’s Laboratories Ltd.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Type:
Branded
Generics

By Application:
HIV
Hepatitis
Herpes
Influenza
Others

By Drug Class:
DNA Polymerase Inhibitors
Reverse Transcriptase Inhibitors
Protease Inhibitors
Neuraminidase Inhibitors
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027

Target Audience of the Global Antiviral Drugs Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

【レポートの目次】

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Antiviral Drugs Market, by Region, 2018-2027 (USD Billion)
1.2.2. Antiviral Drugs Market, by Type, 2018-2027 (USD Billion)
1.2.3. Antiviral Drugs Market, by Application, 2018-2027 (USD Billion)
1.2.4. Antiviral Drugs Market, by Drug Class, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Antiviral Drugs Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Antiviral Drugs Market Dynamics
3.1. Antiviral Drugs Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Antiviral Drugs Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Antiviral Drugs Market, by Type
5.1. Market Snapshot
5.2. Global Antiviral Drugs Market by Type, Performance – Potential Analysis
5.3. Global Antiviral Drugs Market Estimates & Forecasts by Type 2017-2027 (USD Billion)
5.4. Antiviral Drugs Market, Sub Segment Analysis
5.4.1. Branded
5.4.2. Generics
Chapter 6. Global Antiviral Drugs Market, by Application
6.1. Market Snapshot
6.2. Global Antiviral Drugs Market by Application, Performance – Potential Analysis
6.3. Global Antiviral Drugs Market Estimates & Forecasts by Application 2017-2027 (USD Billion)
6.4. Antiviral Drugs Market, Sub Segment Analysis
6.4.1. HIV
6.4.2. Hepatitis
6.4.3. Herpes
6.4.4. Influenza
6.4.5. Others
Chapter 7. Global Antiviral Drugs Market, by Drug Class
7.1. Market Snapshot
7.2. Global Antiviral Drugs Market by Drug Class – Potential Analysis
7.3. Global Antiviral Drugs Market Estimates & Forecasts by Drug Class 2017-2027 (USD Billion)
7.4. Antiviral Drugs Market, Sub Segment Analysis
7.4.1. DNA Polymerase Inhibitors
7.4.2. Reverse Transcriptase Inhibitors
7.4.3. Protease Inhibitors
7.4.4. Neuraminidase Inhibitors
7.4.5. Others
Chapter 8. Global Antiviral Drugs Market, Regional Analysis
8.1. Antiviral Drugs Market, Regional Market Snapshot
8.2. North America Antiviral Drugs Market
8.2.1. U.S. Antiviral Drugs Market
8.2.1.1. Type breakdown estimates & forecasts, 2017-2027
8.2.1.2. Application breakdown estimates & forecasts, 2017-2027
8.2.1.3. Drug Class breakdown estimates & forecasts, 2017-2027
8.2.2. Canada Antiviral Drugs Market
8.3. Europe Antiviral Drugs Market Snapshot
8.3.1. U.K. Antiviral Drugs Market
8.3.2. Germany Antiviral Drugs Market
8.3.3. France Antiviral Drugs Market
8.3.4. Spain Antiviral Drugs Market
8.3.5. Italy Antiviral Drugs Market
8.3.6. Rest of Europe Antiviral Drugs Market
8.4. Asia-Pacific Antiviral Drugs Market Snapshot
8.4.1. China Antiviral Drugs Market
8.4.2. India Antiviral Drugs Market
8.4.3. Japan Antiviral Drugs Market
8.4.4. Australia Antiviral Drugs Market
8.4.5. South Korea Antiviral Drugs Market
8.4.6. Rest of Asia Pacific Antiviral Drugs Market
8.5. Latin America Antiviral Drugs Market Snapshot
8.5.1. Brazil Antiviral Drugs Market
8.5.2. Mexico Antiviral Drugs Market
8.6. Rest of The World Antiviral Drugs Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Gilead Sciences
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. F. Hoffmann-La Roche AG
9.2.3. GlaxoSmithKline plc.
9.2.4. AbbVie
9.2.5. Merck & Co., Inc.
9.2.6. Johnson & Johnson Services, Inc.
9.2.7. Bristol-Myers Squibb Company
9.2.8. Cipla Inc.
9.2.9. Aurobindo Pharma
9.2.10. Dr. Reddy’s Laboratories Ltd.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

List of Tables
TABLE 1. Global Antiviral Drugs market, report scope
TABLE 2. Global Antiviral Drugs market estimates & forecasts by region 2017-2027 (USD Billion)
TABLE 3. Global Antiviral Drugs market estimates & forecasts by Type 2017-2027 (USD Billion)
TABLE 4. Global Antiviral Drugs market estimates & forecasts by Application 2017-2027 (USD Billion)
TABLE 5. Global Antiviral Drugs market estimates & forecasts by Drug Class 2017-2027 (USD Billion)
TABLE 6. Global Antiviral Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 7. Global Antiviral Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 8. Global Antiviral Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 9. Global Antiviral Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 10. Global Antiviral Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 11. Global Antiviral Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 12. Global Antiviral Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 13. Global Antiviral Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 14. Global Antiviral Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 15. Global Antiviral Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 16. Global Antiviral Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 17. Global Antiviral Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 18. Global Antiviral Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 19. Global Antiviral Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 20. Global Antiviral Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 21. Global Antiviral Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 22. U.S. Antiviral Drugs market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 23. U.S. Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 24. U.S. Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 25. Canada Antiviral Drugs market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 26. Canada Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 27. Canada Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 28. UK Antiviral Drugs market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 29. UK Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 30. UK Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 31. Germany Antiviral Drugs market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 32. Germany Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 33. Germany Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 34. France Antiviral Drugs market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 35. France Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 36. France Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 37. Spain Antiviral Drugs market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 38. Spain Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 39. Spain Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 40. Italy Antiviral Drugs market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 41. Italy Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 42. Italy Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 43. ROE Antiviral Drugs market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 44. ROE Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 45. ROE Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 46. China Antiviral Drugs market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 47. China Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 48. China Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 49. India Antiviral Drugs market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 50. India Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 51. India Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 52. Japan Antiviral Drugs market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 53. Japan Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 54. Japan Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 55. Australia Antiviral Drugs market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 56. Australia Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 57. Australia Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 58. South Korea Antiviral Drugs market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 59. South Korea Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 60. South Korea Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 61. ROPAC Antiviral Drugs market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 62. ROPAC Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 63. ROPAC Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 64. Brazil Antiviral Drugs market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 65. Brazil Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 66. Brazil Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 67. Mexico Antiviral Drugs market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 68. Mexico Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 69. Mexico Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 70. ROLA Antiviral Drugs market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 71. ROLA Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 72. ROLA Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 73. ROW Antiviral Drugs market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 74. ROW Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 75. ROW Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 76. List of secondary sources, used in the study of global Antiviral Drugs market
TABLE 77. List of primary sources, used in the study of global Antiviral Drugs market
TABLE 78. Years considered for the study
TABLE 79. Exchange rates considered

List of figures
FIG 1. Global Antiviral Drugs market, research methodology
FIG 2. Global Antiviral Drugs market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Antiviral Drugs market, key trends 2019
FIG 5. Global Antiviral Drugs market, growth prospects 2020-2027
FIG 6. Global Antiviral Drugs market, porters 5 force Model
FIG 7. Global Antiviral Drugs market, pest analysis
FIG 8. Global Antiviral Drugs market, value chain analysis
FIG 9. Global Antiviral Drugs market by segment, 2017 & 2027 (USD Billion)
FIG 10. Global Antiviral Drugs market by segment, 2017 & 2027 (USD Billion)
FIG 11. Global Antiviral Drugs market by segment, 2017 & 2027 (USD Billion)
FIG 12. Global Antiviral Drugs market by segment, 2017 & 2027 (USD Billion)
FIG 13. Global Antiviral Drugs market by segment, 2017 & 2027 (USD Billion)
FIG 14. Global Antiviral Drugs market by segment, 2017 & 2027 (USD Billion)
FIG 15. Global Antiviral Drugs market by segment, 2017 & 2027 (USD Billion)
FIG 16. Global Antiviral Drugs market by segment, 2017 & 2027 (USD Billion)
FIG 17. Global Antiviral Drugs market, regional snapshot 2017 & 2027
FIG 18. North America Antiviral Drugs market 2017 & 2027 (USD Billion)
FIG 19. Europe Antiviral Drugs market 2017 & 2027 (USD Billion)
FIG 20. Asia-Pacific Antiviral Drugs market 2017 & 2027 (USD Billion)
FIG 21. Latin America Antiviral Drugs market 2017 & 2027 (USD Billion)
FIG 22. Global Antiviral Drugs market, company market share analysis (2019)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の抗ウイルス薬市場2020-2027:種類別(ブランド、ジェネリック)、用途別、薬剤クラス別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆